ConductScience.org, home

Trial · NCT00924326

Adverse events1,170

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherALT, SGPT (serum glutamic pyruvic transaminase)Metabolism and nutrition disorders1x10^9-1x10^10 Cells/kg + High-dose Interleukin-2080
otherALT, SGPT (serum glutamic pyruvic transaminase)Metabolism and nutrition disorders1x10^9-1x10^10 Cells/kg + High-dose Interleukin-2 Retreat030
otherALT, SGPT (serum glutamic pyruvic transaminase)Metabolism and nutrition disorders0.5x10^7 Cells/kg020
otherALT, SGPT (serum glutamic pyruvic transaminase)Metabolism and nutrition disorders2.5x10^6 Cells/kg050
otherALT, SGPT (serum glutamic pyruvic transaminase)Metabolism and nutrition disorders1.0x10^6 Cells/kg060
otherALT, SGPT (serum glutamic pyruvic transaminase)Metabolism and nutrition disorders1.0x10^6 Cells/kg (Reduced Chemo)171
otherALT, SGPT (serum glutamic pyruvic transaminase)Metabolism and nutrition disorders2.0x10^6 Cells/kg (Reduced Chemo)1101
otherALT, SGPT (serum glutamic pyruvic transaminase)Metabolism and nutrition disorders6.0x10^6 Cells/kg (Reduced Chemo)010
otherALT, SGPT (serum glutamic pyruvic transaminase)Metabolism and nutrition disorders2.0x10^6 Cells/kg (Moderate Chemo)020
otherALT, SGPT (serum glutamic pyruvic transaminase)Metabolism and nutrition disorders2.0x10^6 Cells/kg (9-12 Days Culture)020
otherAST, SGOT(serum glutamic oxaloacetic transaminase)Metabolism and nutrition disorders1x10^9-1x10^10 Cells/kg + High-dose Interleukin-2282
otherAST, SGOT(serum glutamic oxaloacetic transaminase)Metabolism and nutrition disorders1x10^9-1x10^10 Cells/kg + High-dose Interleukin-2 Retreat030
otherAST, SGOT(serum glutamic oxaloacetic transaminase)Metabolism and nutrition disorders0.5x10^7 Cells/kg020
otherAST, SGOT(serum glutamic oxaloacetic transaminase)Metabolism and nutrition disorders2.5x10^6 Cells/kg050
otherAST, SGOT(serum glutamic oxaloacetic transaminase)Metabolism and nutrition disorders1.0x10^6 Cells/kg060
otherAST, SGOT(serum glutamic oxaloacetic transaminase)Metabolism and nutrition disorders1.0x10^6 Cells/kg (Reduced Chemo)171
otherAST, SGOT(serum glutamic oxaloacetic transaminase)Metabolism and nutrition disorders2.0x10^6 Cells/kg (Reduced Chemo)1101
otherAST, SGOT(serum glutamic oxaloacetic transaminase)Metabolism and nutrition disorders6.0x10^6 Cells/kg (Reduced Chemo)010
otherAST, SGOT(serum glutamic oxaloacetic transaminase)Metabolism and nutrition disorders2.0x10^6 Cells/kg (Moderate Chemo)020
otherAST, SGOT(serum glutamic oxaloacetic transaminase)Metabolism and nutrition disorders2.0x10^6 Cells/kg (9-12 Days Culture)020

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00924326/events